Joel Ackerman became our Chief Financial Officer in February 2017 after serving as our Senior Vice President, Finance from February 2017 to February 2017. Effective April 2019, Mr. Ackerman was also appointed to serve as our Treasurer. Prior to joining us, Mr. Ackerman was the chief executive officer and a member of the board of directors of Champions Oncology, Inc., a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, since October 2010. Mr. Ackerman is currently the chairman of the board of Champions Oncology. Mr. ...read more